Leerink Swann Downgrades Coventry Health Care (CVH) to Market Perform; Valuation Call

June 20, 2012 7:18 AM EDT Send to a Friend
Get Alerts CVH Hot Sheet
Price: $49.99 --0%

Rating Summary:
    1 Buy, 15 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 19 | New: 22
Trade CVH Now!
Leerink Swann downgraded Coventry Health Care (NYSE: CVH) from Outperform to Market Perform with a price target range of $34-37.

Analyst, Jason Gruda, said, "We are downgrading CVH as it has reached our valuation range ahead of the Supreme Court’s ruling on healthcare reform. Interestingly, the shares are 4% higher than where they were before CVH reported 1Q results and reduced its 2012 operating guidance by nearly $0.60/share. While we aren’t making a specific prediction, we believe there is a chance the individual mandate could be overturned by itself, which could pose a potential near-term risk to the shares. With yesterday’s gain, the partial relief in the troubled Kentucky Medicaid business announced yesterday seems to be priced in."

For an analyst ratings summary and ratings history on Coventry Health Care click here. For more ratings news on Coventry Health Care click here.

Shares of Coventry Health Care closed at $34.19 yesterday, with a 52 week range of $25.78-$37.86.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Downgrades

Add Your Comment